UA93063C2 - Способ лечения склеродермии с применением фрагментов коллагена - Google Patents

Способ лечения склеродермии с применением фрагментов коллагена

Info

Publication number
UA93063C2
UA93063C2 UAA200806641A UAA200806641A UA93063C2 UA 93063 C2 UA93063 C2 UA 93063C2 UA A200806641 A UAA200806641 A UA A200806641A UA A200806641 A UAA200806641 A UA A200806641A UA 93063 C2 UA93063 C2 UA 93063C2
Authority
UA
Ukraine
Prior art keywords
collagen
sclerodermia
treatment
present
collagen fragments
Prior art date
Application number
UAA200806641A
Other languages
English (en)
Ukrainian (uk)
Inventor
Арнольд Е. Паслтвейт
Ендрю Г. Канг
Original Assignee
Дзе Юнввьоситв Ов Теннессв Рвсьоч Фаундейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Юнввьоситв Ов Теннессв Рвсьоч Фаундейшн filed Critical Дзе Юнввьоситв Ов Теннессв Рвсьоч Фаундейшн
Publication of UA93063C2 publication Critical patent/UA93063C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
UAA200806641A 2005-11-16 2006-11-16 Способ лечения склеродермии с применением фрагментов коллагена UA93063C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73719405P 2005-11-16 2005-11-16

Publications (1)

Publication Number Publication Date
UA93063C2 true UA93063C2 (ru) 2011-01-10

Family

ID=38049272

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200806641A UA93063C2 (ru) 2005-11-16 2006-11-16 Способ лечения склеродермии с применением фрагментов коллагена

Country Status (13)

Country Link
US (3) US7718765B2 (ru)
EP (1) EP1965813A4 (ru)
JP (1) JP2009515983A (ru)
KR (1) KR20080073747A (ru)
CN (1) CN101309694B (ru)
AU (1) AU2006315428B2 (ru)
BR (1) BRPI0618699A2 (ru)
CA (1) CA2627974A1 (ru)
EA (1) EA015764B1 (ru)
HK (1) HK1124260A1 (ru)
IL (1) IL190926A0 (ru)
UA (1) UA93063C2 (ru)
WO (1) WO2007059211A2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5030973B2 (ja) 2006-01-13 2012-09-19 インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション あるｉｐｆ（特発性肺線維症）患者が、ｖ型コラーゲンによる経口寛容治療の候補であるかを決定するための方法
JP6422993B2 (ja) * 2014-11-11 2018-11-14 株式会社ニッピ 免疫賦活化剤、細胞性免疫賦活化剤およびｔ細胞数増加剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962025A (en) * 1996-07-16 1999-10-05 The University Of Tennessee Research Corporation Method for treatment of systemic sclerosis and related fibrotic diseases
GB9806806D0 (en) * 1998-03-30 1998-05-27 Univ Cambridge Tech Peptides and uses thereof
US20050197283A1 (en) * 1998-10-04 2005-09-08 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
JP2001002584A (ja) * 1999-06-15 2001-01-09 Collagen Gijutsu Kenshukai Kk 強皮症の症状改善剤
US20030060438A1 (en) * 2000-08-18 2003-03-27 Henry James L. Oligonucleotides and other modulators of the NK-1 receptor pathway and therapeutic uses thereof
US7037534B2 (en) * 2001-10-24 2006-05-02 Aphios Corporation Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds
EP2322185A3 (en) * 2001-11-21 2011-08-10 The Board Of Trustees Of The Leland Stanford Junior University Polynucleotide therapy
BR0315054A (pt) * 2002-11-01 2005-08-16 Boys Town Nat Res Hospital Ligando induzìvel para a integrina alfa 1 beta 1 e empregos
US7854927B2 (en) * 2004-05-11 2010-12-21 Ganeden Biotech, Inc. Methods and compositions for the dietary management of autoimmune disorders
DE102006049185A1 (de) * 2006-10-18 2008-04-24 Bayerl, Thomas M., Prof. Dr. Verwendung von Deuteriumdioxid zur Behandlung von hyperproliferativen Erkrankungen der Haut
US8410067B2 (en) * 2007-11-06 2013-04-02 Benaroya Research Institute Inhibition of versican with siRNA and other molecules
US20090215708A1 (en) * 2008-02-21 2009-08-27 Bradley Stuart Galer Treatment of Sexual Dysfunction with Proton Pump Agonists
US20130165502A1 (en) * 2008-09-18 2013-06-27 The Ohio State University Diagnostic, Prognostic and Therapeutic Uses of miRs in Adaptive Pathways and Disease Pathways
US10765376B2 (en) * 2014-04-09 2020-09-08 University Of Rochester Method and apparatus to diagnose the metastatic or progressive potential of cancer, fibrosis and other diseases

Also Published As

Publication number Publication date
HK1124260A1 (en) 2009-07-10
US20070142286A1 (en) 2007-06-21
US7718765B2 (en) 2010-05-18
CN101309694A (zh) 2008-11-19
US20140107035A1 (en) 2014-04-17
WO2007059211A3 (en) 2007-12-13
IL190926A0 (en) 2009-09-22
JP2009515983A (ja) 2009-04-16
KR20080073747A (ko) 2008-08-11
WO2007059211A2 (en) 2007-05-24
EP1965813A4 (en) 2012-07-04
AU2006315428A1 (en) 2007-05-24
BRPI0618699A2 (pt) 2011-09-06
CA2627974A1 (en) 2007-05-24
EA015764B1 (ru) 2011-12-30
EP1965813A2 (en) 2008-09-10
US20100179096A1 (en) 2010-07-15
CN101309694B (zh) 2012-07-04
AU2006315428B2 (en) 2011-12-01
EA200801136A1 (ru) 2008-08-29

Similar Documents

Publication Publication Date Title
WO2009137217A8 (en) Therapeutic replenishment and enrichment of ocular surface lubrication
TW200510349A (en) Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
MX2007000304A (es) Metodo de tratamiento de enfermedad de almacenamiento de glucogeno o polisacaridos.
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
HK1070575A1 (en) Use of botulinum toxin for treating cardiovasculardiseases
CO6341486A2 (es) Tratamiento y profilaxis de amiloidosis
SG10201903512SA (en) Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases
ZA200802811B (en) Therapy for the treatment of disease
SG148850A1 (en) Methods of treating vascular disease
NZ550026A (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
NO20045056L (no) Fremgangsmater for behandling av hepatitt
NO20044562L (no) Fremgangsmater for behandling av tarmslyng
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
SG10201407403UA (en) Treatments For Gastrointestinal Disorders
BR112014027010A2 (pt) uso de laquinimod de alta dose para tratamento de esclerose múltipla
EP2279244A4 (en) METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
MX2014002471A (es) Combinaciones sinergicas de los inhibidores de p13k y mek.
CA2632207C (en) Use of calcitonin for the treatment of ra
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
WO2007096396A3 (en) Methods for treating autoimmune or demyelinating diseases
ATE535237T1 (de) Verwendung von fts zur behandlung von malignen erkrankungen
EP1262197A3 (en) Combination treatment for sleep disorders including sleep apnea
RU2011123367A (ru) Способ лечения или профилактики тромбоза с использованием этексилата дабигатрана или его соли с улучшенной эффективностью по сравнению со стандартным лечением варфарином
UA93063C2 (ru) Способ лечения склеродермии с применением фрагментов коллагена